Navigation

Hepatitis B - telbivudine

Telbivudine for the treatment of chronic hepatitis B

Status: History
Expected date of issue: August 2008
Process: STA
Topic area:
 

NICE project team

Executive Lead: Gillian Leng
Technical Lead: Ebeenezer Tetteh
Communications manager: Alice Law
Project manager: Christopher Feinmann
Assessment Group / Evidence Review Group: Southampton Health Technology Assessment Centre, University of Southampton
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 26 November 2007
1st appraisal committee meeting: 12 March 2008
2nd appraisal committee meeting 08 May 2008
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers / Sponsors

  • Novartis Pharmaceuticals UK Ltd (telbivudine)

Patient / Carer Groups

  • British Liver Trust
  • Chinese National Healthy Living Centre
  • Hepatitis B Foundation
  • South Asian Health Foundation

Professional Groups

  • Association of Clinical Microbiologists
  • Association of Medical Microbiologists
  • British Association for the Study of the Liver
  • British Association for the Study of the Liver Nurses Forum (BASLNF)
  • British Infection Society
  • British Society of Gastroenterology
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians

Others

  • Bury PCT
  • Department of Health
  • Worcestershire PCT
  • Welsh Assembly Government

General

  • Department of Health, Social Services and Public Health Safety for Northern Ireland
  • NHS Quality Improvement Scotland

Possible comparator manufacturer(s)

  • Gilead Sciences (adefovir dipivoxil)
  • Roche Products Limited (interferon alfa 2a, peginterferon alfa 2a)
  • Schering-Plough Ltd (interferon alfa 2a, interferon alfa 2b)
  • Bristol-Myers Squibb Pharmaceuticals Ltd (entecavir)

Relevant research groups

  • Foundation for Liver Research
  • MRC Clinical Trials Unit

Evidence Review Group

  • Southampton Health Technology Assessment Centre (SHTAC)
  • National Coordinating Centre for Health Technology Assessment

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 27 April 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.